Effects of lipid-lowering treatment on platelet reactivity and platelet-leukocyte aggregation in diabetic patients without and with chronic kidney disease: a randomized trial

By Almquist Tora   Jacobson Stefan H.   Lins Per-Eric   Farndale Richard W.   Hjemdahl Paul  

Nephrology Dialysis Transplantation, Vol. 27, Iss. 9, 2012-09 ,pp. : 3540-3546

Oxford University Press

Access to resources Recommend Favorite

Atorvastatin: beyond lipid-lowering effects in the diabetic population

By Ramos Julie   Khan Qamar A   Thoenes Martin   Khan Bobby V  

Future Cardiology, Vol. 2, Iss. 5, 2006-09 ,pp. : 527-533

Future Medicine

Access to resources Recommend Favorite

Glucose Lowering Activity of the Aqueous Extract of Warionia saharae in Normal and Diabetic Rats

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 16, Iss. 1, 2018-05 ,pp. : 66-72

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetic kidney disease: new treatment options

By Thomas Merlin C  

Diabetes Management, Vol. 3, Iss. 2, 2013-03 ,pp. : 123-130

Future Medicine

Access to resources Recommend Favorite

Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: a nationwide follow-up study

By Horsdal H.  

Diabetologia, Vol. 51, Iss. 4, 2008-04 ,pp. : 567-574

Springer Publishing Company

Access to resources Recommend Favorite